Timothy R Wessel

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)
    Timothy R Wessel
    University of Florida, Division of Cardiovascular Medicine, Gainesville, FL 32610 0277, USA
    Clin Cardiol 30:69-74. 2007
  2. ncbi Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women
    Timothy R Wessel
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL 32610 0277, USA
    JAMA 292:1179-87. 2004
  3. ncbi Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
    Christopher B Arant
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
    Clin Cardiol 32:244-50. 2009
  4. ncbi Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study
    Eileen Handberg
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida 32610 0277, USA
    J Am Coll Cardiol 47:S44-9. 2006
  5. ncbi Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
    Gregory O von Mering
    University of Florida College of Medicine, Gainesville, Fla 32610-0277, USA
    Circulation 109:722-5. 2004
  6. ncbi Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study
    Issam Zineh
    Department of Pharmacy Practice and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
    Pharmacotherapy 26:1572-7. 2006
  7. ncbi Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study
    Christopher B Arant
    University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida 32610 0277, USA
    J Am Coll Cardiol 43:2009-14. 2004
  8. ncbi Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST)
    Issam Zineh
    Department of Pharmacy Practice, College of Pharmacy University of Florida, Gainesville, Florida 32610, USA
    Clin Cardiol 28:321-8. 2005
  9. ncbi CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78)
    Issam Zineh
    University of Florida College of Pharmacy, Department of Pharmacy Practice, 1600 SW Archer Road, Room PG 06, PO Box 100486, Gainesville, FL 32610, USA
    Cytokine 33:258-63. 2006
  10. ncbi Complementary and alternative medicine use among individuals participating in research: implications for research and practice
    Gregory J Welder
    Department of Pharmacy Practice and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
    Pharmacotherapy 26:1794-801. 2006

Detail Information

Publications16

  1. ncbi Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)
    Timothy R Wessel
    University of Florida, Division of Cardiovascular Medicine, Gainesville, FL 32610 0277, USA
    Clin Cardiol 30:69-74. 2007
    ..Accordingly, the relationship between adenosine-related microvascular coronary reactivity and risk factors in symptomatic women evaluated for suspected ischemia remains uncertain...
  2. ncbi Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women
    Timothy R Wessel
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL 32610 0277, USA
    JAMA 292:1179-87. 2004
    ..Individual contributions of obesity and physical fitness (physical activity and functional capacity) to risk of coronary heart disease in women remain unclear...
  3. ncbi Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
    Christopher B Arant
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
    Clin Cardiol 32:244-50. 2009
    ..Inflammatory marker and hemoglobin levels (eg biomarkers) considered separately, predict adverse events in selected populations...
  4. ncbi Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study
    Eileen Handberg
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida 32610 0277, USA
    J Am Coll Cardiol 47:S44-9. 2006
    ..We investigated the relationship between coronary vascular reactivity and functional capacity as assessed from the Duke Activity Status Index (DASI) in a cohort of women evaluated for suspected ischemia...
  5. ncbi Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
    Gregory O von Mering
    University of Florida College of Medicine, Gainesville, Fla 32610-0277, USA
    Circulation 109:722-5. 2004
    ..006). CONCLUSIONS: In women in this study, impaired coronary vasomotor response to acetylcholine was independently linked to adverse cardiovascular outcomes regardless of CAD severity...
  6. ncbi Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study
    Issam Zineh
    Department of Pharmacy Practice and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
    Pharmacotherapy 26:1572-7. 2006
    ....
  7. ncbi Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study
    Christopher B Arant
    University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida 32610 0277, USA
    J Am Coll Cardiol 43:2009-14. 2004
    ..This study was designed to investigate the relationship between hemoglobin level (Hgb) and adverse cardiovascular outcomes in women with suspected ischemia...
  8. ncbi Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST)
    Issam Zineh
    Department of Pharmacy Practice, College of Pharmacy University of Florida, Gainesville, Florida 32610, USA
    Clin Cardiol 28:321-8. 2005
    ..These disparities warrant further investigation to define appropriate care for patients with hypertension and stable CAD from an international public health perspective...
  9. ncbi CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78)
    Issam Zineh
    University of Florida College of Pharmacy, Department of Pharmacy Practice, 1600 SW Archer Road, Room PG 06, PO Box 100486, Gainesville, FL 32610, USA
    Cytokine 33:258-63. 2006
    ..Our findings add to the strength of CXCL5 as candidate gene in future disease-gene and pharmacogenetic association studies...
  10. ncbi Complementary and alternative medicine use among individuals participating in research: implications for research and practice
    Gregory J Welder
    Department of Pharmacy Practice and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
    Pharmacotherapy 26:1794-801. 2006
    ....
  11. ncbi Commentary on "new and emerging theories of cardiovascular disease"
    Timothy R Wessel
    Division of Cardiovascular Medicine at the University of Florida College of Medicine, Gainesville, FL 32610, USA
    Biol Res Nurs 6:17-20; discussion 21-3. 2004
  12. ncbi Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations
    Richard S Schofield
    Division of Cardiovascular Medicine and Shands Transplant Center, University of Florida College of Medicine, Gainesville, Florida, USA
    Clin Cardiol 26:407-10. 2003
    ..Hyperhomocysteinemia is becoming recognized as a risk factor for cardiovascular disease, yet there are limited data on the prevalence of hyperhomocysteinemia in patients with heart failure...
  13. ncbi Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors
    Issam Zineh
    Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA
    Pharmacotherapy 26:333-40. 2006
    ....
  14. ncbi The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
    Leslee J Shaw
    Division of Cardiology, Department of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    J Am Coll Cardiol 47:S36-43. 2006
    ..Our objective was to determine the prognostic value of estimated metabolic equivalents (METs) based on self-reported functional capacity by the Duke Activity Status Index (DASI) in symptomatic women...
  15. ncbi Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study
    Kevin E Kip
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA
    Am Heart J 150:900-6. 2005
    ..However, no studies have collectively evaluated how inflammatory markers cluster empirically and relate to angiographic coronary artery disease and CVD events...
  16. ncbi Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies
    Leslee J Shaw
    Division of Cardiology, Department of Medicine, Cedars Sinai Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA
    J Am Coll Cardiol 47:S4-S20. 2006
    ....